Assessing the impact of multidrug-resistant tuberculosis in children: an exploratory qualitative study

Caroline Franck1, James A Seddon, Anneke C Hesseling

  • 1Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK. caroline.franck@ladydavis.ca.

Insights

Multidrug-resistant tuberculosis (MDR-TB) treatment significantly impacts children and families psychologically, academically, and financially. Psychosocial support is crucial to manage stigma and chronic illness stressors for pediatric MDR-TB patients.

Area of Science:

  • Pediatric infectious diseases
  • Public health
  • Psychology

Background:

  • High prevalence of multidrug-resistant tuberculosis (MDR-TB) in children in the Western Cape, South Africa.
  • Limited understanding of the psychosocial impact of MDR-TB treatment on affected children.

Purpose of the Study:

  • To explore the individual, familial, and social impacts of MDR-TB and its treatment on children.
  • To identify challenges and support needs for pediatric MDR-TB patients and their caregivers.

Main Methods:

  • Semi-structured interviews with 20 children and caregivers from a clinical cohort.
  • Stratified sampling by age group (children >10 years and 5-10 years).
  • Grounded theory analysis of qualitative data.

Main Results:

  • Medication side effects and pill burden caused physical, psychological, and academic distress, hindering treatment adherence.
  • Younger children showed no lasting effects, but some older children experienced internalized stigma.
  • Caregivers faced financial and psychological burdens; community support and social networks fostered resilience.

Conclusions:

  • Childhood MDR-TB treatment imposes significant psychological, academic, and financial burdens on children and families.
  • Essential to provide psychosocial support to mitigate stigma and manage chronic illness stressors.
  • Addressing the holistic needs of pediatric MDR-TB patients is critical for successful outcomes.
Abstract

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
978
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
400
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
810
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
206
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.7K